| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.851 | 0.003 | 0.851 | 5 Hydroxytryptamine release stimulant | 0.851 0.003 CID_11405 0.839 0.003 CID_179091 | ||
| 0.808 | 0.004 | 0.815 | Psychostimulant | 0.713 0.004 CID_11405 0.815 0.004 CID_179091 | CID_179091 | |
| 0.718 | 0.022 | 0.785 | Caspase 9 stimulant | 0.616 0.034 CID_11405 0.785 0.013 CID_179091 | CID_179091 | |
| 0.683 | 0.034 | 0.718 | Apoptosis agonist | 0.718 0.028 CID_11405 0.709 0.029 CID_179091 | CID_11405 | |
| 0.554 | 0.017 | 0.596 | Spasmolytic | 0.589 0.014 CID_11405 0.596 0.013 CID_179091 | CID_179091 | |
| 0.49 | 0.005 | 0.56 | 5 Hydroxytryptamine uptake stimulant | 0.56 0.003 CID_11405 0.469 0.005 CID_179091 | CID_11405 | |
| 0.471 | 0.02 | 0.494 | Vasodilator, coronary | 0.418 0.03 CID_11405 0.494 0.016 CID_179091 | CID_179091 | |
| 0.479 | 0.04 | 0.479 | 5 Hydroxytryptamine release inhibitor | 0.443 0.054 CID_11405 0.477 0.04 CID_179091 | ||
| 0.46 | 0.027 | 0.49 | Caspase 3 stimulant | 0.458 0.028 CID_11405 0.49 0.022 CID_179091 | CID_179091 | |
| 0.444 | 0.054 | 0.473 | Calcium channel L-type activator | 0.473 0.039 CID_11405 0.46 0.045 CID_179091 | CID_11405 | |
| 0.384 | 0.01 | 0.482 | Tyrosine 3 hydroxylase inhibitor | 0.437 0.005 CID_11405 0.482 0.004 CID_179091 | CID_179091 | |
| 0.42 | 0.049 | 0.454 | Vasodilator, peripheral | 0.389 0.059 CID_11405 0.454 0.039 CID_179091 | CID_179091 | |
| 0.379 | 0.05 | 0.6 | Aldehyde oxidase inhibitor | 0.525 0.029 CID_11405 0.6 0.019 CID_179091 | CID_179091 | |
| 0.299 | 0.033 | 0.307 | Gastrin inhibitor | 0.307 0.028 CID_11405 0.256 0.072 CID_179091 | CID_11405 | |
| 0.28 | 0.017 | 0.317 | MAO A inhibitor | 0.314 0.014 CID_11405 0.317 0.013 CID_179091 | CID_179091 | |
| 0.262 | 0.012 | 0.278 | Bronchodilator | 0.278 0.01 CID_11405 0.273 0.011 CID_179091 | CID_11405 | |
| 0.297 | 0.049 | 0.331 | Vasodilator | 0.297 0.049 CID_11405 0.331 0.039 CID_179091 | CID_179091 | |
| 0.319 | 0.073 | 0.319 | Calcium channel activator | 0.274 0.12 CID_11405 0.301 0.091 CID_179091 | ||
| 0.342 | 0.104 | 0.4 | Histamine release inhibitor | 0.4 0.076 CID_11405 0.392 0.08 CID_179091 | CID_11405 | |
| 0.247 | 0.017 | 0.247 | 5 Hydroxytryptamine 3E antagonist | 0.244 0.019 CID_11405 0.185 0.092 CID_179091 | ||
| 0.364 | 0.136 | 0.364 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.359 0.141 CID_11405 | ||
| 0.308 | 0.086 | 0.425 | Cholesterol antagonist | 0.425 0.045 CID_11405 0.364 0.059 CID_179091 | CID_11405 | |
| 0.285 | 0.063 | 0.285 | Cardiotonic | 0.236 0.092 CID_11405 0.243 0.088 CID_179091 | ||
| 0.243 | 0.021 | 0.243 | Anesthetic local | 0.239 0.022 CID_11405 0.209 0.03 CID_179091 | ||
| 0.242 | 0.022 | 0.27 | Neurotensin receptor agonist | 0.258 0.02 CID_11405 0.27 0.018 CID_179091 | CID_179091 | |
| 0.239 | 0.02 | 0.239 | 5 Hydroxytryptamine 2B antagonist | 0.134 0.049 CID_11405 0.162 0.036 CID_179091 | ||
| 0.286 | 0.068 | 0.342 | Insulysin inhibitor | 0.342 0.037 CID_11405 0.298 0.059 CID_179091 | CID_11405 | |
| 0.226 | 0.009 | 0.226 | 5 Hydroxytryptamine 1F antagonist | 0.162 0.015 CID_11405 0.145 0.017 CID_179091 | ||
| 0.299 | 0.088 | 0.334 | Antithrombotic | 0.317 0.078 CID_11405 0.334 0.07 CID_179091 | CID_179091 | |
| 0.246 | 0.037 | 0.26 | Insulin sensitizer | 0.259 0.03 CID_11405 0.26 0.029 CID_179091 | CID_179091 | |
| 0.269 | 0.065 | 0.327 | Interleukin agonist | 0.327 0.036 CID_11405 0.282 0.057 CID_179091 | CID_11405 | |
| 0.234 | 0.032 | 0.267 | MAO inhibitor | 0.267 0.025 CID_11405 0.257 0.026 CID_179091 | CID_11405 | |
| 0.201 | 0.004 | 0.201 | 5 Hydroxytryptamine 2 agonist | 0.106 0.008 CID_11405 0.128 0.006 CID_179091 | ||
| 0.247 | 0.052 | 0.335 | Anesthetic general | 0.335 0.026 CID_11405 0.27 0.042 CID_179091 | CID_11405 | |
| 0.262 | 0.067 | 0.346 | Superoxide dismutase inhibitor | 0.346 0.037 CID_11405 0.331 0.041 CID_179091 | CID_11405 | |
| 0.237 | 0.043 | 0.264 | Nitric-oxide synthase stimulant | 0.231 0.048 CID_11405 0.264 0.024 CID_179091 | CID_179091 | |
| 0.258 | 0.066 | 0.258 | 5 Hydroxytryptamine 1E antagonist | 0.223 0.105 CID_11405 0.235 0.091 CID_179091 | ||
| 0.291 | 0.099 | 0.421 | Transcription factor NF kappa B inhibitor | 0.355 0.075 CID_11405 0.421 0.059 CID_179091 | CID_179091 | |
| 0.222 | 0.031 | 0.265 | Tubulin antagonist | 0.134 0.067 CID_11405 0.265 0.023 CID_179091 | CID_179091 | |
| 0.258 | 0.068 | 0.371 | Antiamyloidogenic | 0.284 0.057 CID_11405 0.371 0.034 CID_179091 | CID_179091 | |
| 0.197 | 0.01 | 0.197 | Sphingomyelinase inhibitor | 0.156 0.022 CID_11405 0.177 0.015 CID_179091 | ||
| 0.256 | 0.078 | 0.299 | Transcription factor STAT3 inhibitor | 0.299 0.054 CID_11405 0.27 0.069 CID_179091 | CID_11405 | |
| 0.296 | 0.119 | 0.356 | Antiobesity | 0.356 0.084 CID_11405 0.25 0.156 CID_179091 | CID_11405 | |
| 0.246 | 0.069 | 0.246 | Calpain inhibitor | 0.236 0.078 CID_11405 0.212 0.102 CID_179091 | ||
| 0.18 | 0.004 | 0.18 | 5 Hydroxytryptamine 2A agonist | 0.122 0.009 CID_11405 0.175 0.004 CID_179091 | ||
| 0.192 | 0.018 | 0.192 | 5 Hydroxytryptamine 2C antagonist | 0.081 0.06 CID_11405 0.119 0.036 CID_179091 | ||
| 0.18 | 0.009 | 0.281 | Adrenaline agonist | 0.281 0.004 CID_11405 0.247 0.005 CID_179091 | CID_11405 | |
| 0.181 | 0.011 | 0.181 | Alpha adrenoreceptor agonist | 0.149 0.016 CID_11405 0.168 0.013 CID_179091 | ||
| 0.181 | 0.016 | 0.181 | Calcium antagonist | 0.075 0.068 CID_11405 0.106 0.043 CID_179091 | ||
| 0.287 | 0.123 | 0.287 | Calpain 2 inhibitor | 0.258 0.144 CID_11405 0.206 0.182 CID_179091 | ||
| 0.183 | 0.023 | 0.191 | Falcipain 3 inhibitor | 0.191 0.02 CID_11405 0.159 0.032 CID_179091 | CID_11405 | |
| 0.162 | 0.011 | 0.204 | Beta tubulin antagonist | 0.145 0.013 CID_11405 0.204 0.007 CID_179091 | CID_179091 | |
| 0.17 | 0.02 | 0.215 | Papain-like protease (SARS coronavirus) inhibitor | 0.215 0.008 CID_11405 0.178 0.017 CID_179091 | CID_11405 | |
| 0.158 | 0.008 | 0.158 | Glutamate release inhibitor | 0.139 0.013 CID_11405 0.128 0.017 CID_179091 | ||
| 0.213 | 0.064 | 0.285 | Neurotrophic factor enhancer | 0.285 0.023 CID_11405 0.262 0.032 CID_179091 | CID_11405 | |
| 0.167 | 0.025 | 0.192 | Vanilloid 1 agonist | 0.166 0.026 CID_11405 0.192 0.014 CID_179091 | CID_179091 | |
| 0.159 | 0.019 | 0.205 | Prolactin inhibitor | 0.191 0.01 CID_11405 0.205 0.008 CID_179091 | CID_179091 | |
| 0.181 | 0.042 | 0.186 | GABA C receptor rho-2 antagonist | 0.186 0.038 CID_11405 0.181 0.041 CID_179091 | CID_11405 | |
| 0.137 | 0.003 | 0.143 | Baculoviral IAP repeat-containing protein inhibitor | 0.143 0.003 CID_11405 0.103 0.003 CID_179091 | CID_11405 | |
| 0.166 | 0.033 | 0.166 | Alpha 2b adrenoreceptor antagonist | 0.092 0.083 CID_11405 0.13 0.05 CID_179091 | ||
| 0.22 | 0.088 | 0.221 | Neuropeptide Y2 antagonist | 0.221 0.088 CID_11405 0.206 0.109 CID_179091 | CID_11405 | |
| 0.153 | 0.021 | 0.153 | Nitric-oxide synthase inhibitor | 0.144 0.025 CID_11405 0.121 0.037 CID_179091 | ||
| 0.137 | 0.007 | 0.179 | Beta 3 adrenoreceptor antagonist | 0.152 0.005 CID_11405 0.179 0.004 CID_179091 | CID_179091 | |
| 0.136 | 0.007 | 0.178 | Beta adrenoreceptor antagonist | 0.151 0.006 CID_11405 0.178 0.004 CID_179091 | CID_179091 | |
| 0.16 | 0.033 | 0.166 | Microtubule formation inhibitor | 0.151 0.037 CID_11405 0.166 0.03 CID_179091 | CID_179091 | |
| 0.17 | 0.044 | 0.17 | Calcium channel blocker | 0.107 0.104 CID_11405 | ||
| 0.165 | 0.039 | 0.165 | 5 Hydroxytryptamine 2 antagonist | 0.095 0.076 CID_179091 | ||
| 0.198 | 0.073 | 0.265 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.247 0.044 CID_11405 0.265 0.036 CID_179091 | CID_179091 | |
| 0.251 | 0.127 | 0.307 | Apoptosis antagonist | 0.288 0.094 CID_11405 0.307 0.081 CID_179091 | CID_179091 | |
| 0.132 | 0.01 | 0.132 | Granulocyte macrophage colony stimulating factor agonist | 0.115 0.019 CID_11405 0.119 0.016 CID_179091 | ||
| 0.227 | 0.105 | 0.298 | Transcription factor STAT inhibitor | 0.298 0.057 CID_11405 0.242 0.093 CID_179091 | CID_11405 | |
| 0.152 | 0.032 | 0.152 | Nav1.1 sodium channel blocker | 0.143 0.036 CID_11405 0.139 0.038 CID_179091 | ||
| 0.138 | 0.019 | 0.138 | Inducible nitric-oxide synthase inhibitor | 0.123 0.023 CID_11405 0.114 0.027 CID_179091 | ||
| 0.174 | 0.056 | 0.267 | Melanin inhibitor | 0.193 0.044 CID_11405 0.267 0.026 CID_179091 | CID_179091 | |
| 0.157 | 0.041 | 0.157 | Cathepsin H inhibitor | 0.156 0.042 CID_11405 0.114 0.084 CID_179091 | ||
| 0.119 | 0.005 | 0.119 | Sigma 1 receptor antagonist | 0.081 0.007 CID_11405 0.069 0.008 CID_179091 | ||
| 0.159 | 0.045 | 0.159 | Nav1.6 sodium channel blocker | 0.134 0.074 CID_11405 0.137 0.07 CID_179091 | ||
| 0.15 | 0.036 | 0.15 | Antiadrenergic | 0.096 0.058 CID_11405 0.125 0.043 CID_179091 | ||
| 0.16 | 0.048 | 0.205 | Adenylate cyclase stimulant | 0.205 0.011 CID_11405 0.188 0.02 CID_179091 | CID_11405 | |
| 0.146 | 0.036 | 0.209 | Interleukin 8 antagonist | 0.209 0.01 CID_11405 0.166 0.025 CID_179091 | CID_11405 | |
| 0.178 | 0.068 | 0.178 | Tumour necrosis factor antagonist | 0.171 0.076 CID_179091 | ||
| 0.143 | 0.036 | 0.143 | Adrenaline antagonist | 0.091 0.059 CID_11405 0.119 0.044 CID_179091 | ||
| 0.128 | 0.023 | 0.128 | Glutamate (mGluR7) agonist | 0.09 0.084 CID_11405 0.096 0.068 CID_179091 | ||
| 0.182 | 0.078 | 0.194 | P-glycoprotein inhibitor | 0.194 0.068 CID_179091 | CID_179091 | |
| 0.111 | 0.008 | 0.142 | Beta 1 adrenoreceptor antagonist | 0.118 0.007 CID_11405 0.142 0.005 CID_179091 | CID_179091 | |
| 0.122 | 0.024 | 0.127 | Transcription factor NF kappa B stimulant | 0.127 0.022 CID_11405 0.122 0.024 CID_179091 | CID_11405 | |
| 0.109 | 0.012 | 0.109 | Alpha 2 adrenoreceptor agonist | 0.093 0.017 CID_11405 0.094 0.017 CID_179091 | ||
| 0.136 | 0.042 | 0.159 | Mucolytic | 0.142 0.037 CID_11405 0.159 0.027 CID_179091 | CID_179091 | |
| 0.138 | 0.045 | 0.138 | Calcium channel N-type blocker | 0.112 0.074 CID_11405 | ||
| 0.151 | 0.058 | 0.175 | Neurotrophic factor | 0.175 0.041 CID_11405 0.161 0.05 CID_179091 | CID_11405 | |
| 0.145 | 0.053 | 0.151 | Cyclooxygenase 3 inhibitor | 0.116 0.081 CID_11405 0.151 0.047 CID_179091 | CID_179091 | |
| 0.128 | 0.037 | 0.128 | Acetylcholine release stimulant | 0.1 0.089 CID_179091 | ||
| 0.234 | 0.146 | 0.325 | Sodium/bile acid cotransporter inhibitor | 0.317 0.064 CID_11405 0.325 0.058 CID_179091 | CID_179091 | |
| 0.15 | 0.065 | 0.15 | Neuropeptide Y1 antagonist | 0.138 0.085 CID_11405 0.147 0.069 CID_179091 | ||
| 0.103 | 0.018 | 0.103 | Adrenaline uptake inhibitor | 0.093 0.021 CID_11405 0.071 0.033 CID_179091 | ||
| 0.125 | 0.041 | 0.197 | Carbonic anhydrase III inhibitor | 0.195 0.017 CID_11405 0.197 0.017 CID_179091 | CID_179091 | |
| 0.122 | 0.038 | 0.122 | Folate antagonist | 0.11 0.05 CID_11405 0.117 0.042 CID_179091 | ||
| 0.144 | 0.061 | 0.153 | Heat shock protein 70 antagonist | 0.153 0.038 CID_11405 0.153 0.039 CID_179091 | CID_179091 | |
| 0.092 | 0.009 | 0.136 | Beta 2 adrenoreceptor antagonist | 0.124 0.006 CID_11405 0.136 0.005 CID_179091 | CID_179091 | |
| 0.122 | 0.04 | 0.192 | Potassium channel (Ca-activated) activator | 0.192 0.016 CID_11405 0.136 0.033 CID_179091 | CID_11405 | |
| 0.162 | 0.082 | 0.179 | ATPase inhibitor | 0.177 0.062 CID_11405 0.179 0.059 CID_179091 | CID_179091 | |
| 0.142 | 0.062 | 0.142 | Nav1.2 sodium channel blocker | 0.121 0.083 CID_11405 | ||
| 0.141 | 0.061 | 0.278 | Alpha-N-acetylglucosaminidase inhibitor | 0.278 0.019 CID_11405 0.142 0.06 CID_179091 | CID_11405 | |
| 0.127 | 0.049 | 0.127 | Calcium channel (voltage-sensitive) blocker | |||
| 0.162 | 0.084 | 0.162 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.101 | 0.023 | 0.124 | Estrogen-related receptor beta agonist | 0.124 0.009 CID_11405 0.123 0.009 CID_179091 | CID_11405 | |
| 0.133 | 0.056 | 0.154 | Proteasome inhibitor | 0.154 0.044 CID_11405 0.126 0.061 CID_179091 | CID_11405 | |
| 0.135 | 0.059 | 0.135 | Nav1.3 sodium channel blocker | 0.104 0.093 CID_11405 | ||
| 0.223 | 0.147 | 0.223 | Ca(v)3.3 blocker | |||
| 0.112 | 0.036 | 0.112 | Toll-Like receptor 3 antagonist | |||
| 0.115 | 0.04 | 0.132 | Interleukin 1 beta converting enzyme inhibitor | 0.132 0.027 CID_11405 0.113 0.041 CID_179091 | CID_11405 | |
| 0.08 | 0.006 | 0.082 | Immunoglobulin Fc receptor antagonist | 0.082 0.005 CID_11405 0.068 0.012 CID_179091 | CID_11405 | |
| 0.189 | 0.114 | 0.25 | Peptidyltransferase inhibitor | 0.25 0.051 CID_11405 0.232 0.065 CID_179091 | CID_11405 | |
| 0.122 | 0.049 | 0.158 | Expectorant | 0.124 0.048 CID_11405 0.158 0.032 CID_179091 | CID_179091 | |
| 0.181 | 0.11 | 0.202 | Cyclic AMP phosphodiesterase inhibitor | 0.178 0.113 CID_11405 0.202 0.092 CID_179091 | CID_179091 | |
| 0.08 | 0.009 | 0.117 | Beta 2 adrenoreceptor agonist | 0.117 0.004 CID_11405 0.097 0.004 CID_179091 | CID_11405 | |
| 0.091 | 0.021 | 0.091 | Dopamine uptake inhibitor | 0.08 0.025 CID_11405 0.06 0.038 CID_179091 | ||
| 0.133 | 0.063 | 0.152 | Cholinergic antagonist | 0.152 0.051 CID_11405 0.125 0.069 CID_179091 | CID_11405 | |
| 0.107 | 0.038 | 0.123 | Aminoacyl-tRNA synthetase inhibitor | 0.123 0.028 CID_11405 0.117 0.032 CID_179091 | CID_11405 | |
| 0.131 | 0.065 | 0.131 | Antibacterial (Helicobacter pylori) | 0.12 0.081 CID_11405 0.13 0.067 CID_179091 | ||
| 0.085 | 0.019 | 0.085 | Sigma receptor antagonist | 0.075 0.022 CID_11405 0.064 0.026 CID_179091 | ||
| 0.115 | 0.051 | 0.189 | DOPA decarboxylase inhibitor | 0.189 0.008 CID_11405 0.165 0.015 CID_179091 | CID_11405 | |
| 0.127 | 0.064 | 0.145 | Acetylcholine antagonist | 0.145 0.053 CID_11405 0.121 0.07 CID_179091 | CID_11405 | |
| 0.084 | 0.023 | 0.084 | Glutamate (mGluR7) antagonist | 0.069 0.045 CID_179091 | ||
| 0.09 | 0.03 | 0.09 | 5 Hydroxytryptamine uptake inhibitor | 0.058 0.048 CID_11405 | ||
| 0.084 | 0.024 | 0.084 | Potassium channel (ATP-sensitive) blocker | 0.062 0.057 CID_11405 0.07 0.04 CID_179091 | ||
| 0.093 | 0.036 | 0.093 | Cathepsin G inhibitor | 0.093 0.036 CID_11405 0.081 0.043 CID_179091 | ||
| 0.114 | 0.056 | 0.12 | Electron transport complex I inhibitor | 0.12 0.047 CID_179091 | CID_179091 | |
| 0.204 | 0.147 | 0.306 | 12-Lipoxygenase inhibitor | 0.301 0.079 CID_11405 0.306 0.076 CID_179091 | CID_179091 | |
| 0.146 | 0.09 | 0.266 | Growth hormone agonist | 0.266 0.039 CID_11405 0.157 0.082 CID_179091 | CID_11405 | |
| 0.108 | 0.052 | 0.133 | GABA C receptor rho-1 antagonist | 0.133 0.03 CID_11405 0.109 0.051 CID_179091 | CID_11405 | |
| 0.112 | 0.056 | 0.112 | Alpha 2c adrenoreceptor antagonist | 0.085 0.081 CID_179091 | ||
| 0.112 | 0.057 | 0.181 | Aminopeptidase B inhibitor | 0.181 0.026 CID_11405 0.11 0.059 CID_179091 | CID_11405 | |
| 0.087 | 0.033 | 0.087 | Calcium channel L-type blocker | |||
| 0.059 | 0.005 | 0.059 | Melatonin receptor 1A agonist | 0.037 0.017 CID_179091 | ||
| 0.096 | 0.042 | 0.096 | Acetylcholine nicotinic antagonist | 0.074 0.063 CID_11405 0.078 0.057 CID_179091 | ||
| 0.07 | 0.019 | 0.07 | 5 Hydroxytryptamine 7 agonist | 0.063 0.027 CID_179091 | ||
| 0.059 | 0.009 | 0.059 | 5 Hydroxytryptamine 2B agonist | 0.036 0.034 CID_11405 0.038 0.029 CID_179091 | ||
| 0.076 | 0.026 | 0.085 | Caspase 9 inhibitor | 0.085 0.02 CID_11405 0.07 0.031 CID_179091 | CID_11405 | |
| 0.118 | 0.069 | 0.143 | Acetylcholine muscarinic antagonist | 0.143 0.048 CID_11405 0.116 0.071 CID_179091 | CID_11405 | |
| 0.083 | 0.033 | 0.146 | Potassium channel large-conductance Ca-activated activator | 0.146 0.011 CID_11405 0.092 0.028 CID_179091 | CID_11405 | |
| 0.098 | 0.048 | 0.098 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.154 | 0.105 | 0.291 | Amyloid beta aggregation inhibitor | 0.248 0.058 CID_11405 0.291 0.047 CID_179091 | CID_179091 | |
| 0.077 | 0.03 | 0.077 | Protease 3C (Human rhinovirus) inhibitor | 0.077 0.029 CID_11405 0.06 0.052 CID_179091 | ||
| 0.113 | 0.067 | 0.13 | Photosensitizer | 0.13 0.046 CID_11405 0.121 0.056 CID_179091 | CID_11405 | |
| 0.134 | 0.089 | 0.151 | Thiol protease inhibitor | 0.151 0.068 CID_11405 | CID_11405 | |
| 0.135 | 0.09 | 0.169 | Acetylcholine M1 receptor antagonist | 0.169 0.059 CID_11405 0.128 0.097 CID_179091 | CID_11405 | |
| 0.129 | 0.084 | 0.174 | Farnesoid X receptor antagonist | 0.161 0.041 CID_11405 0.174 0.033 CID_179091 | CID_179091 | |
| 0.056 | 0.011 | 0.093 | Beta adrenoreceptor agonist | 0.093 0.004 CID_11405 0.075 0.005 CID_179091 | CID_11405 | |
| 0.055 | 0.012 | 0.055 | Diamine oxidase inhibitor | 0.044 0.019 CID_11405 | ||
| 0.112 | 0.069 | 0.112 | Interleukin 1b antagonist | |||
| 0.104 | 0.062 | 0.132 | Carbonic anhydrase XV inhibitor | 0.123 0.044 CID_11405 0.132 0.039 CID_179091 | CID_179091 | |
| 0.086 | 0.044 | 0.086 | Nicotinic alpha4beta2 receptor antagonist | 0.074 0.057 CID_11405 | ||
| 0.159 | 0.117 | 0.159 | Focal adhesion kinase 2 inhibitor | |||
| 0.044 | 0.003 | 0.047 | Baculoviral IAP repeat-containing protein 3 inhibitor | 0.047 0.003 CID_11405 0.035 0.004 CID_179091 | CID_11405 | |
| 0.066 | 0.025 | 0.085 | Sphingosine kinase 2 inhibitor | 0.085 0.013 CID_11405 0.076 0.017 CID_179091 | CID_11405 | |
| 0.075 | 0.034 | 0.075 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.077 | 0.036 | 0.077 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.078 | 0.038 | 0.078 | Neuronal nicotinic receptor antagonist | 0.062 0.052 CID_179091 | ||
| 0.071 | 0.031 | 0.071 | Bombesin 1 receptor agonist | 0.064 0.037 CID_11405 0.06 0.041 CID_179091 | ||
| 0.142 | 0.102 | 0.186 | Interleukin 6 antagonist | 0.186 0.05 CID_11405 0.154 0.084 CID_179091 | CID_11405 | |
| 0.102 | 0.063 | 0.102 | Gastric antisecretory | |||
| 0.056 | 0.017 | 0.056 | Histamine H2 receptor agonist | 0.053 0.019 CID_11405 | ||
| 0.052 | 0.016 | 0.052 | Plasmepsin II inhibitor | 0.039 0.032 CID_11405 0.042 0.027 CID_179091 | ||
| 0.066 | 0.03 | 0.066 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.095 | 0.06 | 0.11 | Bile acid receptor antagonist | 0.11 0.031 CID_11405 0.109 0.033 CID_179091 | CID_11405 | |
| 0.051 | 0.016 | 0.052 | Histamine H1 receptor agonist | 0.052 0.015 CID_11405 | CID_11405 | |
| 0.1 | 0.065 | 0.109 | Protease inhibitor | 0.109 0.057 CID_11405 0.089 0.076 CID_179091 | CID_11405 | |
| 0.08 | 0.047 | 0.08 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.087 | 0.054 | 0.105 | Myeloperoxidase inhibitor | 0.105 0.029 CID_11405 0.097 0.039 CID_179091 | CID_11405 | |
| 0.045 | 0.012 | 0.045 | Melatonin agonist | 0.034 0.021 CID_179091 | ||
| 0.109 | 0.077 | 0.128 | Caspase 3 inhibitor | 0.128 0.049 CID_11405 0.103 0.087 CID_179091 | CID_11405 | |
| 0.148 | 0.117 | 0.187 | Succinate dehydrogenase inhibitor | 0.187 0.06 CID_11405 0.161 0.093 CID_179091 | CID_11405 | |
| 0.048 | 0.017 | 0.052 | Kainate receptor agonist | 0.052 0.012 CID_11405 0.045 0.02 CID_179091 | CID_11405 | |
| 0.105 | 0.074 | 0.105 | 5 Hydroxytryptamine antagonist | |||
| 0.059 | 0.028 | 0.062 | Nicotinic alpha3beta2 receptor antagonist | 0.062 0.025 CID_11405 | CID_11405 | |
| 0.066 | 0.036 | 0.066 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.052 | 0.023 | 0.052 | Benzodiazepine antagonist | |||
| 0.076 | 0.047 | 0.124 | Aminopeptidase I inhibitor | 0.124 0.018 CID_11405 0.073 0.05 CID_179091 | CID_11405 | |
| 0.212 | 0.184 | 0.251 | Immunosuppressant | 0.251 0.147 CID_11405 0.25 0.148 CID_179091 | CID_11405 | |
| 0.038 | 0.011 | 0.038 | Melatonin antagonist | |||
| 0.087 | 0.06 | 0.136 | Opioid antagonist | 0.136 0.03 CID_11405 0.134 0.031 CID_179091 | CID_11405 | |
| 0.029 | 0.002 | 0.029 | Baculoviral IAP repeat-containing protein 2 inhibitor | 0.027 0.002 CID_11405 0.018 0.003 CID_179091 | ||
| 0.051 | 0.026 | 0.051 | CC chemokine 4 receptor antagonist | |||
| 0.054 | 0.029 | 0.054 | Metalloproteinase-3 inhibitor | 0.043 0.042 CID_11405 0.043 0.041 CID_179091 | ||
| 0.04 | 0.015 | 0.04 | Melatonin 1 agonist | 0.032 0.025 CID_179091 | ||
| 0.083 | 0.059 | 0.083 | Histamine H2 receptor antagonist | |||
| 0.085 | 0.062 | 0.121 | Ornithine decarboxylase inhibitor | 0.121 0.025 CID_11405 0.096 0.049 CID_179091 | CID_11405 | |
| 0.053 | 0.03 | 0.053 | Dopamine transporter inhibitor | 0.048 0.034 CID_11405 | ||
| 0.061 | 0.039 | 0.074 | Carbonic anhydrase stimulant | 0.074 0.029 CID_11405 0.055 0.046 CID_179091 | CID_11405 | |
| 0.069 | 0.047 | 0.069 | 5 Hydroxytryptamine agonist | |||
| 0.06 | 0.039 | 0.093 | Sphingosine kinase inhibitor | 0.093 0.01 CID_11405 0.071 0.024 CID_179091 | CID_11405 | |
| 0.131 | 0.11 | 0.16 | Interferon gamma antagonist | 0.16 0.066 CID_11405 0.158 0.069 CID_179091 | CID_11405 | |
| 0.052 | 0.032 | 0.053 | Lysophosphatidic acid 3 receptor antagonist | 0.053 0.031 CID_11405 | CID_11405 | |
| 0.055 | 0.035 | 0.055 | Matrix metalloproteinase 1 inhibitor | 0.05 0.039 CID_11405 0.053 0.036 CID_179091 | ||
| 0.064 | 0.044 | 0.064 | Calcium channel P-type blocker | |||
| 0.073 | 0.054 | 0.073 | Alpha 2a adrenoreceptor antagonist | |||
| 0.08 | 0.061 | 0.08 | Caspase 7 inhibitor | |||
| 0.041 | 0.022 | 0.043 | VCAM-1 antagonist | 0.043 0.018 CID_11405 0.04 0.024 CID_179091 | CID_11405 | |
| 0.066 | 0.047 | 0.066 | Matrix metalloproteinase inhibitor | 0.062 0.051 CID_11405 0.06 0.054 CID_179091 | ||
| 0.056 | 0.037 | 0.056 | Matrix metalloproteinase (membrane-type) inhibitor | 0.052 0.042 CID_11405 | ||
| 0.041 | 0.022 | 0.043 | VCAM antagonist | 0.043 0.018 CID_11405 0.04 0.025 CID_179091 | CID_11405 | |
| 0.063 | 0.045 | 0.063 | Kallikrein 7 inhibitor | |||
| 0.064 | 0.046 | 0.07 | Neutrophil collagenase inhibitor | 0.07 0.039 CID_11405 0.056 0.055 CID_179091 | CID_11405 | |
| 0.028 | 0.01 | 0.044 | Beta 1 adrenoreceptor agonist | 0.044 0.004 CID_11405 0.039 0.005 CID_179091 | CID_11405 | |
| 0.067 | 0.049 | 0.215 | Phenylalanine 4-hydroxylase inhibitor | 0.215 0.006 CID_11405 0.114 0.02 CID_179091 | CID_11405 | |
| 0.071 | 0.055 | 0.136 | Glutamate dehydrogenase inhibitor | 0.136 0.018 CID_11405 0.072 0.053 CID_179091 | CID_11405 | |
| 0.106 | 0.09 | 0.149 | Transcription factor STAT6 inhibitor | 0.149 0.024 CID_11405 0.105 0.093 CID_179091 | CID_11405 | |
| 0.089 | 0.073 | 0.203 | Creatine kinase inhibitor | 0.203 0.01 CID_11405 0.134 0.032 CID_179091 | CID_11405 | |
| 0.03 | 0.014 | 0.037 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.037 0.009 CID_11405 0.029 0.016 CID_179091 | CID_11405 | |
| 0.073 | 0.058 | 0.091 | GABA B receptor agonist | 0.079 0.044 CID_11405 0.091 0.024 CID_179091 | CID_179091 | |
| 0.07 | 0.054 | 0.07 | Peroxisome proliferator-activated receptor gamma antagonist | 0.068 0.058 CID_11405 0.068 0.059 CID_179091 | ||
| 0.03 | 0.015 | 0.038 | Motilin receptor antagonist | 0.038 0.008 CID_11405 0.029 0.017 CID_179091 | CID_11405 | |
| 0.074 | 0.059 | 0.109 | Somatostatin 1 agonist | 0.109 0.029 CID_11405 0.086 0.045 CID_179091 | CID_11405 | |
| 0.029 | 0.015 | 0.029 | Hedgehog signaling activator | 0.027 0.019 CID_179091 | ||
| 0.07 | 0.056 | 0.07 | Metalloproteinase-9 inhibitor | 0.069 0.058 CID_11405 0.07 0.056 CID_179091 | ||
| 0.033 | 0.02 | 0.041 | Glutamate (mGluR3) agonist | 0.04 0.01 CID_11405 0.041 0.009 CID_179091 | CID_179091 | |
| 0.019 | 0.006 | 0.019 | Melatonin receptor 1A antagonist | |||
| 0.079 | 0.067 | 0.079 | Alpha 2 adrenoreceptor antagonist | |||
| 0.041 | 0.03 | 0.053 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.053 0.012 CID_11405 0.051 0.014 CID_179091 | CID_11405 | |
| 0.029 | 0.018 | 0.029 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.051 | 0.04 | 0.062 | Vanilloid 2 antagonist | 0.049 0.043 CID_11405 0.062 0.02 CID_179091 | CID_179091 | |
| 0.208 | 0.198 | 0.358 | GABA C receptor rho-3 antagonist | 0.358 0.082 CID_11405 0.234 0.169 CID_179091 | CID_11405 | |
| 0.129 | 0.12 | 0.154 | CF transmembrane conductance regulator agonist | 0.149 0.078 CID_11405 0.154 0.069 CID_179091 | CID_179091 | |
| 0.097 | 0.087 | 0.177 | Adenylate cyclase inhibitor | 0.177 0.031 CID_11405 0.127 0.062 CID_179091 | CID_11405 | |
| 0.152 | 0.143 | 0.328 | Free radical scavenger | 0.269 0.061 CID_11405 0.328 0.044 CID_179091 | CID_179091 | |
| 0.02 | 0.011 | 0.02 | Melatonin 1 antagonist | |||
| 0.037 | 0.028 | 0.037 | Potassium channel Kv1.1 blocker | |||
| 0.083 | 0.075 | 0.113 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.113 0.043 CID_11405 | CID_11405 | |
| 0.018 | 0.01 | 0.024 | Ileal bile acid transport inhibitor | 0.017 0.011 CID_11405 0.024 0.007 CID_179091 | CID_179091 | |
| 0.02 | 0.012 | 0.02 | Follicle-stimulating hormone antagonist | |||
| 0.049 | 0.041 | 0.049 | Histamine agonist | |||
| 0.055 | 0.048 | 0.057 | Cathepsin E inhibitor | 0.057 0.045 CID_11405 | CID_11405 | |
| 0.022 | 0.015 | 0.022 | Follicle-stimulating hormone agonist | |||
| 0.093 | 0.087 | 0.096 | Factor V inhibitor | 0.096 0.08 CID_11405 | CID_11405 | |
| 0.129 | 0.123 | 0.145 | Ca2+-transporting ATPase inhibitor | 0.145 0.057 CID_11405 0.13 0.118 CID_179091 | CID_11405 | |
| 0.019 | 0.013 | 0.022 | Antibiotic Anthracycline-like | 0.02 0.011 CID_11405 0.022 0.008 CID_179091 | CID_179091 | |
| 0.043 | 0.038 | 0.043 | Potassium channel Kv1.3 blocker | |||
| 0.039 | 0.034 | 0.039 | Leukocyte elastase inhibitor | |||
| 0.051 | 0.046 | 0.053 | Epithelial sodium channel blocker | 0.053 0.042 CID_11405 | CID_11405 | |
| 0.104 | 0.099 | 0.163 | Toll-Like receptor 2 antagonist | 0.125 0.072 CID_11405 0.163 0.044 CID_179091 | CID_179091 | |
| 0.052 | 0.047 | 0.052 | Alpha 1 adrenoreceptor agonist | |||
| 0.012 | 0.008 | 0.012 | Melatonin 2 antagonist | |||
| 0.021 | 0.018 | 0.021 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.057 | 0.054 | 0.104 | Purinergic P2X2 antagonist | 0.104 0.028 CID_179091 | CID_179091 | |
| 0.111 | 0.11 | 0.299 | Peroxidase inhibitor | 0.278 0.042 CID_11405 0.299 0.038 CID_179091 | CID_179091 | |
| 0.092 | 0.092 | 0.143 | GABA C receptor antagonist | 0.143 0.034 CID_11405 0.101 0.077 CID_179091 | CID_11405 | |
| 0.045 | 0.045 | 0.048 | Collagenase inhibitor | 0.048 0.037 CID_11405 | CID_11405 | |
| 0.038 | 0.04 | 0.059 | Glycine transporter 2 inhibitor | 0.059 0.025 CID_11405 0.054 0.028 CID_179091 | CID_11405 | |
| 0.037 | 0.039 | 0.058 | Sphingosine kinase 1 inhibitor | 0.058 0.01 CID_11405 0.04 0.032 CID_179091 | CID_11405 | |
| 0.05 | 0.053 | 0.055 | Kallikrein 1 inhibitor | 0.055 0.041 CID_11405 | CID_11405 | |
| 0.056 | 0.059 | 0.11 | Opioid mu receptor antagonist | 0.11 0.028 CID_11405 0.105 0.03 CID_179091 | CID_11405 | |
| 0.042 | 0.046 | 0.134 | NMDA 2A receptor antagonist | 0.134 0.008 CID_11405 0.056 0.033 CID_179091 | CID_11405 | |
| 0.059 | 0.064 | 0.167 | Histidine decarboxylase inhibitor | 0.167 0.017 CID_11405 0.117 0.026 CID_179091 | CID_11405 | |
| 0.067 | 0.072 | 0.073 | Metalloproteinase-2 inhibitor | 0.073 0.061 CID_11405 | CID_11405 | |
| 0.05 | 0.055 | 0.077 | Acetylcholine M3 receptor antagonist | 0.077 0.028 CID_11405 0.058 0.044 CID_179091 | CID_11405 | |
| 0.031 | 0.036 | 0.045 | Cathepsin L2 inhibitor | 0.045 0.026 CID_11405 | CID_11405 | |
| 0.02 | 0.026 | 0.026 | ICAM 1 antagonist | 0.026 0.01 CID_11405 | CID_11405 | |
| 0.034 | 0.04 | 0.059 | Oxytocin agonist | 0.059 0.018 CID_11405 0.043 0.029 CID_179091 | CID_11405 | |
| 0.047 | 0.053 | 0.053 | Leukotriene B4 antagonist | 0.052 0.04 CID_11405 0.053 0.039 CID_179091 | CID_179091 | |
| 0.072 | 0.078 | 0.088 | Glutathione S-transferase inhibitor | 0.088 0.05 CID_11405 | CID_11405 | |
| 0.022 | 0.028 | 0.032 | Vanilloid 2 agonist | 0.032 0.008 CID_11405 0.027 0.014 CID_179091 | CID_11405 | |
| 0.059 | 0.066 | 0.079 | Catalase inhibitor | 0.079 0.048 CID_11405 0.067 0.057 CID_179091 | CID_11405 | |
| 0.017 | 0.026 | 0.02 | Leukotriene B4 receptor 2 antagonist | 0.02 0.019 CID_11405 | CID_11405 | |
| 0.08 | 0.09 | 0.168 | Monophenol monooxygenase inhibitor | 0.142 0.05 CID_11405 0.168 0.041 CID_179091 | CID_179091 | |
| 0.016 | 0.026 | 0.019 | Caspase 8 inhibitor | 0.019 0.015 CID_11405 | CID_11405 | |
| 0.062 | 0.072 | 0.08 | Phospholipase D inhibitor | 0.08 0.034 CID_11405 | CID_11405 | |
| 0.015 | 0.025 | 0.03 | Estrogen-related receptor gamma agonist | 0.03 0.004 CID_11405 0.02 0.01 CID_179091 | CID_11405 | |
| 0.063 | 0.074 | 0.09 | Analgesic, opioid | 0.087 0.04 CID_11405 0.09 0.037 CID_179091 | CID_179091 | |
| 0.012 | 0.023 | 0.019 | Aminopeptidase A inhibitor | 0.019 0.011 CID_11405 | CID_11405 | |
| 0.053 | 0.065 | 0.055 | Ryanodine receptor antagonist | 0.055 0.054 CID_179091 | CID_179091 | |
| 0.07 | 0.084 | 0.09 | MAO B inhibitor | 0.09 0.066 CID_11405 0.082 0.073 CID_179091 | CID_11405 | |
| 0.034 | 0.048 | 0.04 | Neurotensin receptor antagonist | 0.04 0.037 CID_179091 | CID_179091 | |
| 0.055 | 0.069 | 0.065 | Histone deacetylase SIRT3 inhibitor | 0.065 0.035 CID_11405 | CID_11405 | |
| 0.035 | 0.05 | 0.06 | Opioid mu receptor agonist | 0.052 0.028 CID_11405 0.06 0.023 CID_179091 | CID_179091 | |
| 0.006 | 0.021 | 0.014 | Beta 3 adrenoreceptor agonist | 0.014 0.006 CID_11405 | CID_11405 | |
| 0.041 | 0.056 | 0.048 | Bombesin 2 receptor antagonist | 0.048 0.036 CID_11405 | CID_11405 | |
| 0.126 | 0.141 | 0.193 | Interleukin antagonist | 0.175 0.1 CID_11405 0.193 0.088 CID_179091 | CID_179091 | |
| 0.066 | 0.082 | 0.071 | Chymotrypsin inhibitor | 0.071 0.069 CID_11405 | CID_11405 | |
| 0.023 | 0.039 | 0.038 | Estrogen-related receptor gamma antagonist | 0.038 0.006 CID_11405 0.029 0.019 CID_179091 | CID_11405 | |
| 0.017 | 0.034 | 0.024 | Leukotriene B4 receptor 1 antagonist | 0.024 0.023 CID_11405 | CID_11405 | |
| 0.115 | 0.134 | 0.171 | Arachidonic acid antagonist | 0.171 0.064 CID_11405 0.13 0.113 CID_179091 | CID_11405 | |
| 0.082 | 0.102 | 0.16 | Cystathionine beta-synthase inhibitor | 0.157 0.037 CID_11405 0.16 0.036 CID_179091 | CID_179091 | |
| 0.027 | 0.047 | 0.036 | Ceramide glucosyltransferase inhibitor | 0.036 0.024 CID_11405 | CID_11405 | |
| 0.042 | 0.063 | 0.099 | Opioid delta receptor antagonist | 0.099 0.03 CID_11405 0.097 0.031 CID_179091 | CID_11405 | |
| 0.02 | 0.042 | 0.048 | Sirtuin 2 inhibitor | 0.048 0.013 CID_11405 | CID_11405 | |
| 0.062 | 0.084 | 0.085 | Keratolytic | 0.083 0.045 CID_11405 0.085 0.043 CID_179091 | CID_179091 | |
| 0.089 | 0.111 | 0.104 | TRPA1 agonist | 0.104 0.08 CID_11405 0.103 0.083 CID_179091 | CID_11405 | |
| 0.078 | 0.102 | 0.121 | Anabolic | 0.121 0.039 CID_11405 0.101 0.061 CID_179091 | CID_11405 | |
| 0.169 | 0.192 | 0.232 | Hypoxia-inducible factor 1 alpha inhibitor | 0.189 0.166 CID_11405 0.232 0.117 CID_179091 | CID_179091 | |
| 0.027 | 0.051 | 0.035 | Glutamate (mGluR3) antagonist | 0.035 0.028 CID_11405 | CID_11405 | |
| 0.048 | 0.073 | 0.08 | NMDA receptor agonist | 0.08 0.029 CID_11405 | CID_11405 | |
| 0.021 | 0.047 | 0.028 | Purinergic P2Y15 antagonist | 0.028 0.022 CID_11405 | CID_11405 | |
| 0.063 | 0.089 | 0.083 | Vanilloid 4 agonist | 0.083 0.036 CID_11405 | CID_11405 | |
| 0.145 | 0.172 | 0.303 | Antioxidant | 0.262 0.077 CID_11405 0.303 0.061 CID_179091 | CID_179091 | |
| 0.072 | 0.099 | 0.095 | Urease inhibitor | 0.092 0.076 CID_11405 0.095 0.073 CID_179091 | CID_179091 | |
| 0.08 | 0.109 | 0.219 | Chelator | 0.219 0.021 CID_11405 0.139 0.04 CID_179091 | CID_11405 | |
| 0.067 | 0.095 | 0.091 | MAP kinase kinase 7 inhibitor | 0.091 0.023 CID_11405 0.081 0.045 CID_179091 | CID_11405 | |
| 0.107 | 0.135 | 0.115 | Sphingosine 1-phosphate receptor 2 antagonist | 0.115 0.11 CID_11405 | CID_11405 | |
| 0.116 | 0.146 | 0.223 | Angiogenesis stimulant | 0.211 0.089 CID_11405 0.223 0.083 CID_179091 | CID_179091 | |
| 0.018 | 0.048 | 0.025 | Glutamate (mGluR1) agonist | 0.025 0.015 CID_11405 | CID_11405 | |
| 0.128 | 0.16 | 0.187 | Phospholipase C inhibitor | 0.187 0.054 CID_11405 0.157 0.092 CID_179091 | CID_11405 | |
| 0.027 | 0.059 | 0.064 | Dopamine D5 agonist | 0.064 0.01 CID_11405 0.046 0.021 CID_179091 | CID_11405 | |
| 0.034 | 0.068 | 0.064 | Plasminogen activator inhibitor | 0.064 0.036 CID_11405 | CID_11405 | |
| 0.02 | 0.053 | 0.029 | Calcitonin receptor agonist | 0.029 0.028 CID_11405 | CID_11405 | |
| 0.071 | 0.106 | 0.092 | Vanilloid agonist | 0.092 0.044 CID_179091 | CID_179091 | |
| 0.095 | 0.132 | 0.135 | Protein kinase stimulant | 0.11 0.104 CID_11405 0.135 0.079 CID_179091 | CID_179091 | |
| 0.196 | 0.234 | 0.332 | Antibacterial | 0.332 0.113 CID_11405 0.283 0.149 CID_179091 | CID_11405 | |
| 0.056 | 0.094 | 0.078 | GABA aminotransferase inhibitor | 0.078 0.049 CID_11405 0.069 0.064 CID_179091 | CID_11405 | |
| 0.048 | 0.088 | 0.079 | Sirtuin 1 inhibitor | 0.079 0.036 CID_11405 | CID_11405 | |
| 0.06 | 0.1 | 0.091 | Opioid kappa receptor antagonist | 0.091 0.044 CID_11405 0.09 0.046 CID_179091 | CID_11405 | |
| 0.048 | 0.089 | 0.079 | Carbonic anhydrase XIII inhibitor | 0.079 0.05 CID_179091 | CID_179091 | |
| 0.029 | 0.071 | 0.055 | Opioid agonist | 0.049 0.041 CID_11405 0.055 0.034 CID_179091 | CID_179091 | |
| 0.13 | 0.174 | 0.223 | Immunostimulant | 0.223 0.108 CID_11405 0.193 0.124 CID_179091 | CID_11405 | |
| 0.037 | 0.081 | 0.053 | Alpha-mannosidase inhibitor | 0.053 0.037 CID_11405 | CID_11405 | |
| 0.032 | 0.077 | 0.059 | Alpha tubulin antagonist | 0.059 0.031 CID_179091 | CID_179091 | |
| 0.058 | 0.103 | 0.108 | Histamine N-methyltransferase inhibitor | 0.108 0.039 CID_11405 | CID_11405 | |
| 0.066 | 0.111 | 0.084 | Breast cancer-resistant protein inhibitor | 0.084 0.074 CID_179091 | CID_179091 | |
| 0.077 | 0.123 | 0.099 | Nav1.4 sodium channel blocker | 0.099 0.078 CID_11405 0.094 0.086 CID_179091 | CID_11405 | |
| 0.064 | 0.111 | 0.102 | Potassium channel activator | 0.102 0.046 CID_11405 | CID_11405 | |
| 0.088 | 0.134 | 0.196 | Lipid peroxidase inhibitor | 0.184 0.048 CID_11405 0.196 0.043 CID_179091 | CID_179091 | |
| 0.027 | 0.074 | 0.035 | Glutamate (mGluR8) agonist | 0.035 0.033 CID_11405 | CID_11405 | |
| 0.008 | 0.056 | 0.021 | Nicotinic acid receptor 1 antagonist | 0.021 0.008 CID_11405 | CID_11405 | |
| 0.023 | 0.072 | 0.037 | Erythropoietin receptor agonist | 0.037 0.031 CID_11405 | CID_11405 | |
| 0.025 | 0.076 | 0.072 | Ribonucleoside-diphosphate reductase inhibitor | 0.072 0.028 CID_11405 | CID_11405 | |
| 0.069 | 0.121 | 0.083 | CC chemokine 5 receptor agonist | 0.083 0.053 CID_11405 | CID_11405 | |
| 0.025 | 0.077 | 0.074 | Ribonucleotide reductase inhibitor | 0.074 0.029 CID_11405 | CID_11405 | |
| 0.02 | 0.073 | 0.032 | Opioid delta receptor agonist | 0.032 0.031 CID_179091 | CID_179091 | |
| 0.015 | 0.07 | 0.03 | Thyroid hormone agonist | 0.03 0.012 CID_11405 0.024 0.022 CID_179091 | CID_11405 | |
| 0.108 | 0.164 | 0.122 | Sphingosine 1-phosphate receptor 5 antagonist | 0.122 0.119 CID_11405 | CID_11405 | |
| 0.026 | 0.082 | 0.042 | Geranyltranstransferase inhibitor | 0.042 0.033 CID_11405 | CID_11405 | |
| 0.065 | 0.123 | 0.08 | ATPase (Vacuolar H+) inhibitor | 0.08 0.079 CID_179091 | CID_179091 | |
| 0.031 | 0.09 | 0.062 | Argininosuccinate synthase inhibitor | 0.062 0.036 CID_11405 | CID_11405 | |
| 0.073 | 0.132 | 0.099 | Cholesterol synthesis inhibitor | 0.096 0.094 CID_11405 0.099 0.088 CID_179091 | CID_179091 | |
| 0.064 | 0.123 | 0.091 | NADH dehydrogenase inhibitor | 0.091 0.055 CID_11405 | CID_11405 | |
| 0.148 | 0.208 | 0.212 | DNA synthesis inhibitor | 0.212 0.106 CID_11405 0.18 0.154 CID_179091 | CID_11405 | |
| 0.024 | 0.085 | 0.055 | NMDA receptor subunit 3B antagonist | 0.055 0.022 CID_11405 | CID_11405 | |
| 0.037 | 0.1 | 0.065 | Botulinum neurotoxin type A inhibitor | 0.065 0.031 CID_11405 | CID_11405 | |
| 0.047 | 0.111 | 0.059 | Heme oxygenase stimulant | 0.059 0.049 CID_11405 | CID_11405 | |
| 0.066 | 0.129 | 0.093 | D-Ala-D-Ala ligase inhibitor | 0.093 0.04 CID_11405 | CID_11405 | |
| 0.044 | 0.109 | 0.093 | Glutamate decarboxylase inhibitor | 0.093 0.034 CID_11405 0.074 0.05 CID_179091 | CID_11405 | |
| 0.111 | 0.176 | 0.146 | Antimitotic | 0.146 0.125 CID_179091 | CID_179091 | |
| 0.017 | 0.083 | 0.051 | NMDA receptor subunit 3A antagonist | 0.051 0.019 CID_11405 | CID_11405 | |
| 0.041 | 0.107 | 0.067 | Heat shock protein 90 beta antagonist | 0.067 0.031 CID_11405 0.057 0.045 CID_179091 | CID_11405 | |
| 0.042 | 0.108 | 0.066 | Na+ K+ transporting ATPase inhibitor | 0.066 0.064 CID_11405 | CID_11405 | |
| 0.093 | 0.161 | 0.12 | Phospholipase A2 inhibitor | 0.12 0.116 CID_11405 | CID_11405 | |
| 0.144 | 0.214 | 0.193 | RNA-directed DNA polymerase inhibitor | 0.193 0.111 CID_11405 0.174 0.144 CID_179091 | CID_11405 | |
| 0.102 | 0.172 | 0.157 | Nitric oxide antagonist | 0.13 0.12 CID_11405 0.157 0.089 CID_179091 | CID_179091 | |
| 0.101 | 0.173 | 0.154 | Pyruvate kinase inhibitor | 0.154 0.112 CID_11405 0.143 0.122 CID_179091 | CID_11405 | |
| 0.052 | 0.124 | 0.077 | Carbonic anhydrase VI inhibitor | 0.077 0.062 CID_179091 | CID_179091 | |
| 0.009 | 0.082 | 0.031 | Arginase inhibitor | 0.031 0.03 CID_11405 | CID_11405 | |
| 0.101 | 0.178 | 0.138 | DNA methyltransferase I inhibitor | 0.138 0.118 CID_179091 | CID_179091 | |
| 0.038 | 0.115 | 0.08 | Purinergic P2X1 antagonist | 0.08 0.025 CID_11405 | CID_11405 | |
| 0.071 | 0.152 | 0.117 | Bone formation stimulant | 0.11 0.096 CID_11405 0.117 0.088 CID_179091 | CID_179091 | |
| 0.049 | 0.133 | 0.078 | Glycine receptor antagonist | 0.078 0.06 CID_11405 | CID_11405 | |
| 0.031 | 0.116 | 0.046 | Topoisomerase II beta inhibitor | 0.046 0.04 CID_11405 | CID_11405 | |
| 0.13 | 0.217 | 0.196 | Hypoglycemic | 0.196 0.116 CID_179091 | CID_179091 | |
| 0.058 | 0.148 | 0.125 | GABA C receptor agonist | 0.125 0.047 CID_11405 | CID_11405 | |
| 0.194 | 0.284 | 0.296 | Cyclophilin D inhibitor | 0.296 0.166 CID_11405 0.259 0.202 CID_179091 | CID_11405 | |
| 0.063 | 0.163 | 0.097 | Protein kinase C gamma inhibitor | 0.097 0.083 CID_11405 | CID_11405 | |
| 0.077 | 0.178 | 0.146 | Histone deacetylase SIRT1 inhibitor | 0.146 0.065 CID_11405 | CID_11405 | |
| 0.068 | 0.171 | 0.094 | Adenylate kinase inhibitor | 0.094 0.078 CID_11405 | CID_11405 | |
| 0.082 | 0.189 | 0.117 | Diuretic | 0.117 0.108 CID_11405 | CID_11405 | |
| 0.065 | 0.173 | 0.09 | Toll-Like receptor 4 antagonist | 0.09 0.089 CID_179091 | CID_179091 | |
| 0.127 | 0.236 | 0.208 | Lipoxygenase inhibitor | 0.188 0.153 CID_11405 0.208 0.132 CID_179091 | CID_179091 | |
| 0.023 | 0.132 | 0.049 | Alcohol oxidase inhibitor | 0.049 0.046 CID_11405 | CID_11405 | |
| 0.054 | 0.164 | 0.122 | UDP-glucose 4-epimerase inhibitor | 0.122 0.042 CID_11405 | CID_11405 | |
| 0.069 | 0.18 | 0.102 | Aldehyde dehydrogenase inhibitor | 0.102 0.094 CID_11405 | CID_11405 | |
| 0.008 | 0.121 | 0.025 | AMPA 3 receptor antagonist | 0.025 0.024 CID_11405 | CID_11405 | |
| 0.059 | 0.175 | 0.114 | Amylase inhibitor | 0.114 0.085 CID_179091 | CID_179091 | |
| 0.084 | 0.203 | 0.139 | Heat shock protein 90 antagonist | 0.139 0.086 CID_11405 0.123 0.109 CID_179091 | CID_11405 | |
| 0.156 | 0.282 | 0.294 | Interleukin 2 agonist | 0.294 0.078 CID_11405 0.228 0.145 CID_179091 | CID_11405 | |
| 0.025 | 0.152 | 0.057 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.057 0.033 CID_11405 | CID_11405 | |
| 0.044 | 0.172 | 0.086 | 5-Lipoxygenase inhibitor | 0.086 0.075 CID_179091 | CID_179091 | |
| 0.037 | 0.167 | 0.103 | NMDA receptor antagonist | 0.103 0.045 CID_11405 | CID_11405 | |
| 0.077 | 0.208 | 0.12 | Cell wall synthesis inhibitor | 0.12 0.099 CID_11405 | CID_11405 | |
| 0.051 | 0.182 | 0.08 | Triose-phosphate isomerase inhibitor | 0.08 0.077 CID_11405 | CID_11405 | |
| 0.05 | 0.182 | 0.09 | Ferrochelatase inhibitor | 0.09 0.083 CID_11405 | CID_11405 | |
| 0.018 | 0.152 | 0.039 | AMPA 4 receptor antagonist | 0.039 0.028 CID_11405 | CID_11405 | |
| 0.087 | 0.223 | 0.142 | Hepatoprotectant | 0.142 0.119 CID_179091 | CID_179091 | |
| 0.019 | 0.157 | 0.072 | NMDA 2 receptor antagonist | 0.072 0.049 CID_11405 | CID_11405 | |
| 0.108 | 0.251 | 0.164 | Catenin beta inhibitor | 0.164 0.077 CID_11405 | CID_11405 | |
| 0.022 | 0.165 | 0.068 | Phosphofructokinase-1 inhibitor | 0.068 0.049 CID_11405 | CID_11405 | |
| 0.059 | 0.207 | 0.117 | Thrombolytic | 0.117 0.114 CID_11405 | CID_11405 | |
| 0.136 | 0.29 | 0.235 | 15-Lipoxygenase inhibitor | 0.222 0.19 CID_11405 0.235 0.177 CID_179091 | CID_179091 | |
| 0.018 | 0.185 | 0.05 | Maillard reaction inhibitor | 0.05 0.043 CID_11405 | CID_11405 | |
| 0.062 | 0.236 | 0.129 | Interleukin 4 antagonist | 0.12 0.085 CID_11405 0.129 0.073 CID_179091 | CID_179091 | |
| 0.044 | 0.218 | 0.07 | Estrogen receptor alpha antagonist | 0.07 0.069 CID_11405 | CID_11405 | |
| 0.022 | 0.214 | 0.103 | Porphobilinogen synthase inhibitor | 0.103 0.034 CID_11405 | CID_11405 | |
| 0.097 | 0.313 | 0.124 | CC chemokine 6 receptor antagonist | 0.124 0.098 CID_11405 | CID_11405 | |
| 0.047 | 0.272 | 0.12 | Protein-tyrosine phosphatase inhibitor | 0.12 0.113 CID_11405 | CID_11405 | |
| 0.024 | 0.281 | 0.099 | M18 aspartyl aminopeptidase inhibitor | 0.099 0.093 CID_179091 | CID_179091 | |
| 0.034 | 0.416 | 0.121 | Estrogen antagonist | 0.113 0.068 CID_11405 0.121 0.052 CID_179091 | CID_179091 | |
| 0.025 | 0.412 | 0.11 | Estrogen receptor beta antagonist | 0.103 0.058 CID_11405 0.11 0.046 CID_179091 | CID_179091 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |